New treatment approach could give IBD patients hope, and be a bonanza for drugmakers Combination therapies may transform care for inflammatory bowel disease, but questions linger

https://www.statnews.com/2026/02/24/ibd-combination-therapy-race-abbvie-lilly-pfizer-merck-jnj/ By Allison DeAngelisFeb. 24, 2026 Biotech Startups and Venture Capital Reporter